Log in to your Inderes Free account to see all free content on this page.
Raysearch Laboratories
181.80 SEK
-12.76 %
Less than 1K followers
RAY B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Raysearch Laboratories
P/E
Median 2019-2025
EV/S
Median 2019-2025
EV/EBIT
Median 2019-2025
Dividend yield
Median 2019-2025
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 107.20 | 82.70 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 |
| Shares | 34.3 | 34.3 | 34.3 | 34.3 | 34.3 | 34.3 | 34.3 |
| Market cap | 3,675.1 | 2,835.2 | 1,937.0 | 2,331.2 | 3,095.7 | 7,405.1 | 7,816.5 |
| Enterprise value | 3,732.0 | 2,812.8 | 2,396.7 | 2,727.1 | 3,281.4 | 7,414.3 | 7,804.0 |
| EV/S | 5.0 | 4.3 | 3.7 | 3.2 | 3.2 | 6.2 | 5.8 |
| EV/EBITDA | 14.9 | 13.4 | 12.2 | 8.0 | 8.2 | 13.3 | 13.4 |
| EV/EBIT | 54.7 | neg. | neg. | 63.8 | 28.6 | 28.5 | 26.7 |
| P/E | 72.9 | neg. | neg. | 98.6 | 37.9 | 36.4 | 34.3 |
| P/B | 5.21 | 4.08 | 2.98 | 3.55 | 4.21 | 8.45 | 7.93 |
| P/S | 5.0 | 4.4 | 3.0 | 2.8 | 3.0 | 6.2 | 5.8 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 2.2 % | 1.4 % | 1.8 % |
| Equity ratio | 55.8 % | 54.0 % | 37.1 % | 35.0 % | 37.7 % | 41.9 % | 49.5 % |
| Gearing ratio | 24.2 % | 21.1 % | 86.6 % | 84.6 % | 72.0 % | 53.8 % | 40.1 % |
Login required
This content is only available for logged in users